Within this framework, the discovery that a genetic variation, specifically the EE genotype polymorphism of ICAM-1, significantly amplifies the susceptibility to PAD, underscores the notion that a pro-inflammatory status contributes significantly to the development of PAD [83]. The gene discussed is ICAM1; the disease is peripheral arterial disease.